Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug
- PMID: 3540968
- PMCID: PMC304247
- DOI: 10.1073/pnas.84.2.551
Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug
Abstract
"Anti-liver/kidney microsome" (anti-LKM) autoantibodies have been found in the serum of patients with cryptogenic chronic hepatitis and with immunoallergic drug-induced hepatitis, such as those induced by halothane or by tienilic acid (called anti-LKM2 in this case). So far the nature of the human microsomal macromolecules recognized by these antibodies has not been determined. Here we show, by using immunoblot techniques, that among the macromolecules present in human adult liver microsomes, one protein called cytochrome P-450-8 is specifically recognized by most sera of patients containing anti-LKM2 antibodies but not by control serum. Human fetal liver microsomes that do not contain cytochrome P-450-8 are not recognized by the anti-LKM2 antibodies. It is also shown that anti-cytochrome P-450-8 antibodies as well as human serum containing anti-LKM2 antibodies specifically inhibit the hydroxylation of tienilic acid by human liver microsomes. These results indicate that anti-LKM2 antibodies appearing in patients with hepatitis and concomitant administration of tienilic acid are directed against a cytochrome P-450 isoenzyme that catalyzes the metabolic oxidation of this drug. This suggests a possible mechanism for the appearance of anti-organelle antibodies in a drug-induced hepatitis.
Similar articles
-
Detection of human hepatitis anti-liver kidney microsomes (LKM2) autoantibodies on rat liver sections is predominantly due to reactivity with rat liver P-450 IIC11.J Pharmacol Exp Ther. 1991 Dec;259(3):1328-34. J Pharmacol Exp Ther. 1991. PMID: 1762080
-
Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs.Chem Res Toxicol. 1994 May-Jun;7(3):434-42. doi: 10.1021/tx00039a023. Chem Res Toxicol. 1994. PMID: 8075377
-
A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis.Clin Exp Immunol. 1984 Mar;55(3):561-70. Clin Exp Immunol. 1984. PMID: 6368059 Free PMC article.
-
Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.Hepatology. 1997 Oct;26(4):1054-66. doi: 10.1002/hep.510260438. Hepatology. 1997. PMID: 9328334 Review.
-
Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases.Can J Gastroenterol. 2000 May;14(5):429-39. doi: 10.1155/2000/910107. Can J Gastroenterol. 2000. PMID: 10851284 Review.
Cited by
-
Chromosomal organization of the cytochrome P450-2C gene family in the mouse: a locus associated with constitutive aryl hydrocarbon hydroxylase.Proc Natl Acad Sci U S A. 1988 Apr;85(8):2662-6. doi: 10.1073/pnas.85.8.2662. Proc Natl Acad Sci U S A. 1988. PMID: 2895926 Free PMC article.
-
Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.J Clin Invest. 1996 Sep 15;98(6):1471-80. doi: 10.1172/JCI118936. J Clin Invest. 1996. PMID: 8823314 Free PMC article.
-
Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis.Br J Clin Pharmacol. 1995 Oct;40(4):379-86. doi: 10.1111/j.1365-2125.1995.tb04560.x. Br J Clin Pharmacol. 1995. PMID: 8554940 Free PMC article.
-
An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.J Gastroenterol. 2016 Jun;51(6):597-607. doi: 10.1007/s00535-015-1131-7. Epub 2015 Oct 30. J Gastroenterol. 2016. PMID: 26519284
-
Mechanism-based inactivation of CYP450 enzymes: a case study of lapatinib.Drug Metab Rev. 2015 Feb;47(1):21-8. doi: 10.3109/03602532.2014.1003648. Epub 2015 Feb 2. Drug Metab Rev. 2015. PMID: 25639891 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical